Innospec
Valuation each multiple against its own 5-year range
Vs. peers Specialty Chemicals
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Innospec (IOSP) | 1.86B | 13.35 | 1.36 | 2.37% |
| Linde (LIN) | 230.84B | 33.39 | 5.86 | 1.25% |
| Ecolab (ECL) | 82.65B | 40.10 | 7.93 | 0.99% |
| Sherwin-Williams (SHW) | 82.08B | 31.25 | 20.64 | 0.94% |
| Air Products & Chemicals (APD) | 66.16B | 124.31 | 4.63 | 2.43% |
| PPG Industries (PPG) | 25.87B | 16.71 | 3.05 | 2.45% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 14.2% below Morningstar's fair value estimate.
Fair value
Innospec Inc is assigned a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 7% discount to our quantitative fair value estimate of $86.32 per share, which is reinforced by this estimate's low uncertainty rating.
The firm's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 71.3%, which ranks in the top 45% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 96.6%, a core component of profitability, falls in the top 40% compared with peers globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Innospec discussion 0 comments